fr

EN DE

fr

EN DE

Publications

1929 PUBLICATIONS - effacer la recherche

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

2024

BMC cancer

Molière S

MMP-11 expression in early luminal breast cancer: associations with clinical, MRI, pathological characteristics, and disease-free survival.

2024

European journal of cancer (Oxford, England : 1990)

Boidot R

Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer.

2024

Gene therapy

Guerriaud M

Are genetically modified protozoa eligible for ATMP status? Concerning the legal categorization of an oncolytic protozoan drug candidate.

2024

Journal of gynecology obstetrics and human reproduction

Mahiou K

Impact of breast surgical procedure on survival in BRCA mutated patients with invasive breast cancer: mastectomy versus conservative treatment.

2024

PloS one

Deshpande A

TTLL12 has a potential oncogenic activity, suppression of ligation of nitrotyrosine to the C-terminus of detyrosinated α-tubulin, that can be overcome by molecules identified by screening a compound library.

2024

Cancers

Vogin G

Evaluation of the Prognostic Value of Pretherapeutic Magnetic Resonance Imaging in Predicting Soft Tissue Sarcoma Radiation Response: A Retrospective Study from a Large Institutional Sarcoma Imaging Database.

2024

Cancers

Swaminathan G

Implications in Cancer of Nuclear Micro RNAs, Long Non-Coding RNAs, and Circular RNAs Bound by PRC2 and FUS.

2024

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Prétet JL

Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance.

2024

International journal of laboratory hematology

Leveque A

Transient red blood cell agglutination after Magrolimab administration in acute myeloid leukemia.

2024

Breast cancer research : BCR

Scheffges C

Identification of CD160-TM as a tumor target on triple negative breast cancers: possible therapeutic applications.